Sunnyvale, Calif.-based Accuray has scored FDA clearance for its Radixact treatment delivery platform.
The system includes a stronger linear accelerator, MVCT imaging and helical treatment delivery.
Additionally, the agency cleared the company’s Precision treatment planning system and iDMS data management system.
The company expects to launch the Radixact system in 2017. — Anisa Jibrell